The present invention provides a new synthetic process for the production of 1 (2 ((2 4 dimethylphenyl)thio)phenyl)piperazine (vortioxetine) a drug for the treatment of depression and anxiety which is conducted via (2 4 dimethylphenyl)(2 iodophenyl)sulfane intermediate.